The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Promoting inclusion in clinical trials—a rapid review of the literature and recommendations for action
Open accessAbstract
Background: Without inclusion of diverse research participants, it is challenging to understand how study findings will translate into the real world. Despite this, a lack of inclusion of those from under-served groups in research is a prevailing problem due to multi-faceted barriers acting at multiple levels. Therefore, we rapidly reviewed international published literature, in relation to clinical trials, on barriers relating to inclusion, and evidence of approaches that are effective in overcoming these. Methods: A rapid literature review was conducted searching PubMed for peer-reviewed articles that discussed barriers to inclusion or strategies to improve inclusion in clinical trial research published between 2010 and 2021. Grey literature articles were excluded. Results: Seventy-two eligible articles were included. The main barriers identified were language and communication, lack of trust, access to trials, eligibility criteria, attitudes and beliefs, lack of knowledge around clinical trials, and logistical and practical issues. In relation to evidence-based strategies and enablers, two key themes arose: [1] a multi-faceted approach is essential [2]; no single strategy was universally effective either within or between trials. The key evidence-based strategies identified were cultural competency training, community partnerships, personalised approach, multilingual materials and staff, communication-specific strategies, increasing understanding and trust, and tackling logistical barriers. Conclusions: Many of the barriers relating to inclusion are the same as those that impact trial design and healthcare delivery generally. However, the presentation of these barriers among different under-served groups may be unique to each population’s particular circumstances, background, and needs. Based on the literature, we make 15 recommendations that, if implemented, may help improve inclusion within clinical trials and clinical research more generally. The three main recommendations include improving cultural competency and sensitivity of all clinical trial staff through training and ongoing personal development, the need to establish a diverse community advisory panel for ongoing input into the research process, and increasing recruitment of staff from under-served groups. Implementation of these recommendations may help improve representation of under-served groups in clinical trials which would improve the external validity of associated findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Representation of the Elderly, Women, and Minorities in Heart Failure Clinical Trials
Heiat, A., Gross, C. P., & Krumholz, H. M. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.15.1682 · Cited by 723 · cited 1×
“The recommendations focus on 6 areas/strategies: [1] research staff covering the need for improving cultural competency and sensitivity of all clinical trial staff through training and ongoing learning, and the need to increase recruitment of staff from under-served groups [2]; communication including personalisation…”
BackgroundDe Las Nueces, D., Hacker, K., DiGirolamo, A., & Hicks, L. S. (2012) · Health Services Research · doi:10.1111/j.1475-6773.2012.01386.x · Cited by 400
Witham, M. D., Anderson, E., Carroll, C., Dark, P. M., Down, K., Hall, A. S., Knee, J., Maier, R. H., Mountain, G. A., Nestor, G., et al. (2020) · Trials · doi:10.1186/s13063-020-04613-7 · Cited by 259 · cited 1×
“increased representation of under-served groups in clinical trial populations) can broadly be considered to coalesce into issues relating to communication between researchers and participants, how trials are designed and delivered, differing agendas of research teams and participant groups, and a lack of trust in the…”
BackgroundRivers, D., August, E. M., Sehovic, I., Lee Green, B., & Quinn, G. P. (2013) · Contemporary Clinical Trials · doi:10.1016/j.cct.2013.03.007 · Cited by 226 · cited 6×
“Using social proof was also a key strategy for improving trust either through participant testimonials [56, 63] or friends and family referrals [30, 64, 69].”
BackgroundInfluentialCoakley, M., Fadiran, E. O., Parrish, L. J., Griffith, R. A., Weiss, E., & Carter, C. (2012) · Journal of Women's Health · doi:10.1089/jwh.2012.3733 · Cited by 186
Rooney, L. K., Bhopal, R., Halani, L., Levy, M. L., Partridge, M. R., Netuveli, G., Car, J., Griffiths, C., Atkinson, J., Lindsay, G., et al. (2011) · Journal of Public Health · doi:10.1093/pubmed/fdq100 · Cited by 106
Horowitz, C. R., Sabin, T., Ramos, M., Richardson, L. D., Hauser, D., Robinson, M., & Fei, K. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0498-x · Cited by 50
Recruiting Chinese Americans into cancer screening intervention trials: Strategies and outcomes
Wang, J. H.-Y., Sheppard, V. B., Liang, W., Ma, G. X., & Maxwell, A. E. (2014) · Clinical Trials · doi:10.1177/1740774513518849 · Cited by 34
Cited by
Tan, Y. Y., Papez, V., Chang, W. H., Mueller, S. H., Denaxas, S., & Lai, A. G. (2022) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(22)00186-6 · Cited by 283
Chow, R., Midroni, J., Kaur, J., Boldt, G., Liu, G., Eng, L., Liu, F.-F., Haibe-Kains, B., Lock, M., & Raman, S. (2023) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djad013 · Cited by 65
Lovell, H., Silverio, S. A., Story, L., Skelton, E., & Matthew, J. (2023) · PLOS ONE · doi:10.1371/journal.pone.0282088 · Cited by 39
Evaluating a tool to improve engagement and recruitment of under-served groups in trials
Morris, L., Dumville, J., Treweek, S., Miah, N., Curtis, F., & Bower, P. (2022) · Trials · doi:10.1186/s13063-022-06747-2 · Cited by 32
Metadata
- Authors
- Bodicoat, D. H., Routen, A. C., Willis, A., Ekezie, W., Gillies, C., Lawson, C., Yates, T., Zaccardi, F., Davies, M. J., & Khunti, K.
- Venue
- Trials
- Published
- 2021-12
- Volume
- 22
- Issue
- 1
- Pages
- 880-880
- ISSN
- 1745-6215 (ISSN-L)
- OpenAlex
- W4200162826
- Cited by
- 227
- References
- 8
- FWCI
- 26.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Promoting inclusion in clinical trials—a rapid review of the literature and recommendations for action. https://app.cochat.ai/papers/10.1186/s13063-021-05849-7
- The paper
- Bodicoat, D. H., Routen, A. C., Willis, A., Ekezie, W., Gillies, C., Lawson, C., Yates, T., Zaccardi, F., Davies, M. J., & Khunti, K. (2021). Promoting inclusion in clinical trials—a rapid review of the literature and recommendations for action. Trials. https://doi.org/10.1186/s13063-021-05849-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.